Impax Labs Inc (IPXL) 31.15 $IPXL What Awaits Aerie

New Post Public Reply Private Reply Replies (0) Message Board

Aug 2, 2016 at 12:04 AM

Impax Labs Inc (IPXL) 31.15 $IPXL

What Awaits Aerie Pharmaceuticals (AERI) in Q2 Earnings?
Zacks Equity Research - Zacks Investment Research - Mon Aug 01, 5:38PM CDT
Aerie Pharmaceuticals, Inc. (AERI) is scheduled to report second-quarter 2016 results after the market closes on Aug 3.
IPXL: 31.15 (-0.27), IRWD: 13.94 (-0.19), AERI: 17.18 (-0.17), EXEL: 9.27 (+0.09)

Exelixis (EXEL) Q2 Earnings Preview: Stock Likely to Gain?
Zacks Equity Research - Zacks Investment Research - Mon Aug 01, 10:55AM CDT
Exelixis, Inc. (EXEL) is scheduled to report second-quarter 2016 results on Aug 3 after the market closes.
IPXL: 31.15 (-0.27), IRWD: 13.94 (-0.19), EXEL: 9.27 (+0.09)

Aegerion (AEGR): What Awaits for the Stock in Q2 Earnings?
Zacks Equity Research - Zacks Investment Research - Mon Aug 01, 9:03AM CDT
Aegerion (AEGR) is expected to report second-quarter 2016 results on Aug 3.
IPXL: 31.15 (-0.27), IRWD: 13.94 (-0.19), AEGR: 1.47 (+0.03), EXEL: 9.27 (+0.09)

Keryx (KERX) Q2 Earnings Preview: Will the Stock Gain?
Zacks Equity Research - Zacks Investment Research - Fri Jul 29, 4:13PM CDT
Keryx Biopharmaceuticals, Inc. (KERX) is expected to report second-quarter 2016 results on Aug 3.
IPXL: 31.15 (-0.27), IRWD: 13.94 (-0.19), KERX: 4.72 (-2.64), EXEL: 9.27 (+0.09)

What's in Store for Prothena (PRTA) This Earnings Season?
Zacks Equity Research - Zacks Investment Research - Fri Jul 29, 3:44PM CDT
Prothena Corporation plc (PRTA) is expected to report second-quarter 2016 results on Aug 2.
IPXL: 31.15 (-0.27), IRWD: 13.94 (-0.19), PRTA: 56.66 (+1.61), EXEL: 9.27 (+0.09)

Whta's in Store for Endocyte (ECYT) this Earnings Season?
Zacks Equity Research - Zacks Investment Research - Thu Jul 28, 9:59AM CDT
Endocyte, Inc. (ECYT) is expected to report second-quarter 2016 results on Aug 2.
IPXL: 31.15 (-0.27), ECYT: 3.18 (unch), IRWD: 13.94 (-0.19), EXEL: 9.27 (+0.09)

Coverage Initiated on Select Healthcare Stocks
ACCESSWIRE - Thu Jul 14, 8:17AM CDT
LONDON, UK / ACCESSWIRE / July 14, 2016 / Active Wall St. announces the list of stocks for today's coverage. Pre-market the Active Wall St. team provides the latest corporate, market and technical events impacting selected stocks on the Healthcare sector. Companies recently under review include Shire, Novartis, Anavex Life Sciences, and Impax Laboratories. See our complete notes on Shire at:
IPXL: 31.15 (-0.27), AVXL: 3.61 (-0.23), SHPG: 194.00 (-0.12), NVS: 83.07 (-0.19)

Teva Raises Q2 Guidance; to Unveil 2016-2019 View
Zacks Equity Research - Zacks Investment Research - Wed Jul 13, 6:47AM CDT
Ahead of its acquisition of Allergan's Generics business, Teva Pharmaceutical (TEVA) raised its second-quarter 2016 guidance for earnings and revenues.
IPXL: 31.15 (-0.27), AGN: 254.86 (+1.91), MYL: 46.74 (-0.05), TEVA: 53.61 (+0.11)

Impax to Report Second Quarter 2016 Results on August 9, 2016
PR Newswire - Thu Jul 07, 7:05AM CDT
Impax Laboratories, Inc. (NASDAQ: IPXL) announced today that the Company will release its second quarter 2016 financial results on Tuesday, August 9, 2016, prior to the open of the U.S. financial markets. The Company will host a conference call and live webcast with the investment community at 8:30 a.m., Eastern Time on August 9, 2016.
IPXL: 31.15 (-0.27)

Impax (IPXL) Stock Declines on Deal to Buy Generic Products
Arpita Dutt - Zacks Investment Research - Wed Jun 22, 9:20AM CDT
Impax's (IPXL) stock declined 11.5% following the company's announcement regarding the acquisition of generic products.
IPXL: 31.15 (-0.27), AGN: 254.86 (+1.91), TEVA: 53.61 (+0.11), AMPH: 16.29 (+0.11)

Upgrade Alert for Impax Laboratories (IPXL)
Comtex SmarTrend(R) - Wed Jun 22, 3:33AM CDT
Impax Laboratories (NASDAQ:IPXL) was upgraded from Underperform to Neutral at BofA/Merrill today. The stock closed yesterday at $28.31 on volume of 3.0 million shares, above average daily volume of 539,000. Potential upside of 70.4% exists for Impax Laboratories, based on a current level of $28.31 and analysts' average consensus price target of $48.25. Impax Laboratories shares should first meet resistance at the 50-day moving average (MA) of $33.81 and find additional resistance at the 200-day MA of $38.86.
IPXL: 31.15 (-0.27)

United and American Science jump, Werner and Impax slump
AP - Tue Jun 21, 3:43PM CDT
NEW YORK (AP) — Stocks that moved substantially or traded heavily on Tuesday:
AGN: 254.86 (+1.91), IPXL: 31.15 (-0.27), CP.TO: 195.61 (+0.79), WERN: 24.96 (-0.16), CP: 150.10 (+0.32), ASEI: 36.97 (+0.06), IMPV: 46.40 (-0.72), UAL: 47.36 (+0.47)

Look for Shares of Impax Laboratories to Potentially Rebound after Yesterday's 11.26% Sell Off
Comtex SmarTrend(R) - Tue Jun 21, 3:09PM CDT
Impax Laboratories (NASDAQ:IPXL) traded in a range yesterday that spanned from a low of $28.11 to a high of $30.00. Yesterday, the shares fell 11.3%, which took the trading range below the 3-day low of $31.31 on volume of 1.5 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
IPXL: 31.15 (-0.27)

Impax Signs Definitive Agreements to Acquire Generic Products
PR Newswire - Tue Jun 21, 6:00AM CDT
Impax Laboratories, Inc. (NASDAQ: IPXL), a specialty pharmaceutical company, today announced that it has signed definitive agreements with Teva Pharmaceutical Industries Ltd. ("Teva"

and affiliates of Allergan plc ("Allergan"

for the acquisition of a broad portfolio of generic products across solid oral, inhalable, injectable and topical dosage forms and the return to Impax of its rights to its pending abbreviated new drug application ("ANDA"

for the generic equivalent to Concerta® (methylphenidate hydrochloride) (the "Transaction"

for an aggregate purchase price of $586 million.
IPXL: 31.15 (-0.27), AGN: 254.86 (+1.91)

Impax to Present at the Goldman Sachs 37th Annual Global Healthcare Conference
PR Newswire - Thu Jun 02, 3:10PM CDT
Impax Laboratories, Inc. (NASDAQ: IPXL) today announced that the Company will present at the Goldman Sachs 37th Annual Global Healthcare Conference on Wednesday, June 8, 2016 at 2:40 p.m. Pacific Time. The conference will be held in Rancho Palos Verdes, CA.
IPXL: 31.15 (-0.27)

Impax Labs reports 1Q loss
Automated Insights - Tue May 10, 5:48AM CDT
HAYWARD, Calif. (AP) _ Impax Laboratories Inc. (IPXL) on Tuesday reported a loss of $10.4 million in its first quarter.
IPXL: 31.15 (-0.27)

Impax Reports First Quarter 2016 Financial Results
PR Newswire - Tue May 10, 5:40AM CDT
Impax Laboratories, Inc. (NASDAQ: IPXL), a specialty pharmaceutical company, today reported first quarter 2016 financial results for the quarter ended March 31, 2016.
IPXL: 31.15 (-0.27)

Is a Surprise Coming for Impax Laboratories (IPXL) This Earnings Season?
Zacks Equity Research - Zacks Investment Research - Mon May 09, 7:48AM CDT
A positive Earnings ESP coupled with impressive Zacks Rank has made Impax Laboratories (IPXL) an interesting choice for the investors.
IPXL: 31.15 (-0.27)

Jazz (JAZZ) Q1 Earnings: A Beat in the Cards for the Stock?
Zacks Equity Research - Zacks Investment Research - Fri May 06, 4:13PM CDT
Jazz Pharmaceuticals (JAZZ), which is set to report first-quarter 2016 results on May 10, delivered a positive earnings surprise of 36.75% last quarter.
IPXL: 31.15 (-0.27), CLSN: 1.22 (-0.01), JAZZ: 150.53 (-0.44)

What's in the Cards for Catalyst (CPRX) in Q1 Earnings?
Zacks Equity Research - Zacks Investment Research - Fri May 06, 11:18AM CDT
Catalyst Pharmaceuticals, Inc. (CPRX) is scheduled to report first-quarter 2016 results on May 10.
IPXL: 31.15 (-0.27), CPRX: 0.76 (+0.04), JAZZ: 150.53 (-0.44), XON: 27.38 (+2.05)

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

USPS Rolls Out Christmas Cookie Stamps Nationwide

USPS Delivers Nostalgia with Cookie-Themed Stamps Let's talk stamps, folks. The U.S. Postal Service has rolled out its newest Christmas Cookies Forever stamps, bringing a dash of sugary nostalgia to mailboxes nationwide. The release was celebrated at the Smithsonian National Postal Museum, spotlighting a tradition as sweet as the sugar cookies themselves. These aren't...

Papa John's Faces Class Action Over Misleading Info

Trouble Brewing for Papa John's Investors Rolling the dice in the stock market sometimes feels like playing the lottery, doesn't it? This time around, it's Papa John's (NASDAQ: PZZA) serving up a slice of turmoil for its investors. The pizza chain's got itself tangled in a class-action lawsuit, and it's the shareholders who're left with a bitter taste. Investors Cry Foul...

BarrelPick.com Launches for Bourbon Aficionados

Just when you think you've seen all the ways to enjoy bourbon, along comes BarrelPick.com with a tantalizing new proposition. They're throwing down the gauntlet for bourbon lovers everywhere by letting you buy an entire barrel, let it sit around for a bit, watch it mature, and then call the shots on when it finally sees the light of day in a bottle. Talk about skipping...

Qatar Foundation Spurs Sport-Driven Empowerment Moves

Here we go, diving into the serious talk of the moment: sports pushing boundaries to uplift society's underdogs. Envision yourself in the halls of Wilton Park, where the thinkers, the dreamers, and the doers convened in the name of change. Qatar Foundation ain't just sitting pretty; they're championing the cause to harness sport for impactful social threads across the...

Flying Car Regulatory Sandbox Begins in UAE

Pioneering Flying Cars in the Desert In a move that seems right out of a science fiction screenplay, ARIDGE—the bigwig of flying cars from Asia—has taken a giant leap. They’ve cozied up with the UAE, locking arms to cook up the world's first regulatory sandbox for personal flying cars. Now, don’t laugh—sandbox isn't just for toddlers. It’s the playground where...

Why Liver Nurture Taps into Health Sector Trends

Liver Wellness: A Sector on the Rise Remember when everyone was all about heart health and cholesterol levels? Seems like these days, folks have shifted their focus a bit south—right to the liver. It's no surprise, really. With our modern diet and lifestyle choices squeezing the life out of this hard-working organ, people are on the hunt for ways to give it the TLC it...

Tragedy Highlights Need for E-bike Safety Overhaul

A Dire Wake-Up Call in the East Village We're staring hard at a heartbreaking mess in the East Village. A 15-year-old girl lost her life while riding an electric Citi Bike, hit by an industrial truck. Let's not dance around it—this is a gut punch, the kind you never want to ever hear about, and one that comes with a bitter flavor of 'what if?' Age Verification: A...

Med Spa Visits: Key Insights from Lindsey Smith

Moving Beyond the Fear Factor Stepping into a med spa for the first time can be nerve-wracking, especially if you're unsure of what to expect. Lindsey Smith, an expert from Flawless Med Spa in Bryant, Arkansas, knows just how critical it is to navigate this terrain with clarity. Her approach emphasizes building a foundation of trust and understanding from the get-go. Fear...

Insta360 Expands with Times Square Flagship Store

Insta360 Times Square Opening Marks Bold Expansion I dropped by Times Square today, and what do I see? Insta360 planting its flag right in the heart of New York City. Now, this isn't your run-of-the-mill grand opening—it’s the first flagship store outside of Asia, and it screams of big ambitions. Nestled at 1515 Broadway, the store is smack in the middle of one of the...